VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Phase 1

Recruiting

Conditions: Solid Tumor, Adult

Interventions: Drug: Neratinib
Drug: Divalproex Sodium

First Posted Date: 2019-04-18

Last Posted Date: 2024-11-06

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 83

Registration Number: NCT03919292

Locations: 🇺🇸
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Identification of microRNAs Involved in Cerebral Collateral Regulation

Suspended

Conditions: Cerebrovascular Disorders

Interventions: Genetic: miRNA sampling

First Posted Date: 2019-04-05

Last Posted Date: 2024-11-04

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 45

Registration Number: NCT03905434

Locations: 🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Assessing the Effects of Auricular Acupressure on Newborns With NAS

Not Applicable

Completed

Conditions: Neonatal Abstinence Syndrome

Interventions: Other: Auricular acupressure

First Posted Date: 2019-03-26

Last Posted Date: 2021-04-13

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 12

Registration Number: NCT03890562

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Enhanced Care Planning for Patients With Multiple Chronic Conditions

Not Applicable

Active, not recruiting

Conditions: Multiple Chronic Conditions
Health Behavior
Mental Health
Social Determinants of Health

Interventions: Behavioral: Enhanced care planning

First Posted Date: 2019-03-21

Last Posted Date: 2024-12-05

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 600

Registration Number: NCT03885401

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Device: PDVibe2

First Posted Date: 2019-03-20

Last Posted Date: 2022-10-21

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 14

Registration Number: NCT03883217

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block

Phase 4

Withdrawn

Conditions: Pain, Chest
Pain, Postoperative

Interventions: Drug: Ropivacaine 0.25%-NaCl 0.9% Injectable Solution
Drug: Ropivacaine 0.2%-NaCl 0.9% Injectable Solution

First Posted Date: 2019-03-14

Last Posted Date: 2019-07-15

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT03874806

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Not Applicable

Withdrawn

Conditions: Parkinson Disease

Interventions: Device: PDVibe2

First Posted Date: 2019-03-13

Last Posted Date: 2024-10-15

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT03872115

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease

Phase 2

Terminated

Conditions: Chronic Kidney Diseases
Hyperuricemia

Interventions: Drug: Allopurinol

First Posted Date: 2019-03-06

Last Posted Date: 2021-05-27

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 17

Registration Number: NCT03865407

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

The Effect of Electronic Cigarette Liquid Characteristics in Smokers.

Not Applicable

Completed

Conditions: Electronic Cigarettes

Interventions: Other: Own Brand Cigarette
Other: ECIG 15 mg nicotine, sweetened
Other: ECIG 15 mg nicotine, unsweet
Other: ECIG 0 mg nicotine, sweetened
Other: ECIG 0 mg nicotine, unsweet

First Posted Date: 2019-03-04

Last Posted Date: 2022-12-23

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 22

Registration Number: NCT03861078

Locations: 🇺🇸
Clinical Behavioral Pharmacology Laboratory, Richmond, Virginia, United States

Self-Managed Intervention for Anxiety in Parkinson's Disease

Not Applicable

Completed

Conditions: Anxiety
Parkinson Disease

Interventions: Behavioral: Focused breathing

First Posted Date: 2019-03-01

Last Posted Date: 2020-01-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 28

Registration Number: NCT03859180

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy